Dongliang Wang
- Cancer Research top 10%
- MicroRNA in disease regulation 4
- Cancer-related molecular mechanisms research 2
- Pharmacology top 5%
- Toxicology top 10%
- Bioactive Compounds and Antitumor Agents 1
-
- Tannin, Tannase and Anticancer Activities 2
-
- Extracellular vesicles in disease 3
- Cell death mechanisms and regulation 2
- Ginseng Biological Effects and Applications 2
-
- Pomegranate: compositions and health benefits 2
- Partner nations
- ChinaJapanUnited States
In The Last Decade
Dongliang Wang
11 papers receiving 612 citations
Peers
Comparison fields: 5 of 77
- Cancer Research 191
- Pharmacology 97
- Toxicology 27
- Applied Microbiology and Biotechnology 14
- Complementary and alternative medicine 55
Countries citing papers authored by Dongliang Wang
This map shows the geographic impact of Dongliang Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dongliang Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dongliang Wang more than expected).
Fields of papers citing papers by Dongliang Wang
This network shows the impact of papers produced by Dongliang Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dongliang Wang. The network helps show where Dongliang Wang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Dongliang Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 4 | |
| 2 | 2024 | 28 | |
| 3 | 2024 | 5 | |
| 4 | 2021 | 154 | |
| 5 | 2020 | 14 | |
| 6 | 2017 | 9 | |
| 7 | 2016 | 32 | |
| 8 | 2016 | 29 | |
| 9 | 2015 | 203 | |
| 10 | 2012 | 18 | |
| 11 | 2010 | 121 |
About Dongliang Wang
Dongliang Wang is a scholar working on Applied Microbiology and Biotechnology, Health Informatics and Toxicology, having authored 11 papers that have together received 617 indexed citations. Recurring topics across this work include MicroRNA in disease regulation (4 papers), Extracellular vesicles in disease (3 papers), Cell death mechanisms and regulation (2 papers), Ginseng Biological Effects and Applications (2 papers), Pomegranate: compositions and health benefits (2 papers), Cancer-related molecular mechanisms research (2 papers), Tannin, Tannase and Anticancer Activities (2 papers) and Bioactive Compounds and Antitumor Agents (1 paper). The work is most often cited by research in Cancer Research (191 citations), Pharmacology (97 citations) and Toxicology (27 citations). Dongliang Wang has collaborated with scholars based in China, Japan and United States. Frequent co-authors include Xianxian He, Xiangshan Zhou, Yunpeng Xu, Yufeng Qin, Mingming Jin, Gang Huang, Liu Liu, Jianjun Liu, Fei Xu and Kunchi Zhang. Their work appears in journals such as Journal of Ethnopharmacology, Advanced Science and Theranostics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.